Actively Recruiting
Impact of an Information Sheet Given to Parents After an Initial Consultation for a Simple Febrile Seizure at Strasbourg University Hospital
Led by University Hospital, Strasbourg, France · Updated on 2026-01-13
100
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Simple febrile seizures (SFS) are a very common phenomenon (2-5% of children), mostly without serious consequences for the child or their development, but extremely anxiety-provoking for parents, who develop a "fear of fever" for fear of a recurrence, and request numerous additional tests, not justified according to current guidelines, after a first episode of SFS. Educating parents about these fever-related crises and fever management, and standardizing the information provided through an explanatory sheet implemented at the SAUP in July 2023, would help reduce consultations for recurrent simple febrile crises, as well as early consultations for isolated fever (reflecting parental anxiety caused by these crises).
CONDITIONS
Official Title
Impact of an Information Sheet Given to Parents After an Initial Consultation for a Simple Febrile Seizure at Strasbourg University Hospital
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Child aged between 9 months and 5 years at the time of consultation at the SAUP (emergency pediatric unit)
- First visit to the SAUP for a simple febrile seizure
- Generalized seizure lasting less than 15 minutes
- No post-critical deficit
- No recurrence of seizures within 24 hours
- No personal history of neurological disorders
- Occurrence between January 1, 2022, and May 1, 2025
- First or second episode of simple febrile seizure at the time of consultation
- Presence of one of the two parents during the consultation at the SAUP
You will not qualify if you...
- Patient already seen at the SAUP for simple febrile seizure
- Child who has already had more than two simple febrile seizures at the time of their emergency visit
- Child younger than 9 months or older than 5 years at diagnosis
- Non-febrile seizure
- Focal seizure
- Seizure lasting more than 15 minutes
- Presence of post-critical deficit
- Multiple seizures within 24 hours
- Personal neurological history
- Seizure occurring outside January 1, 2022 to May 1, 2025
- Absence of parents during the SAUP consultation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Service de pédiatrie 1 - CHU de Strasbourg - France
Strasbourg, France, 67091
Actively Recruiting
Research Team
S
Sarah Baer, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here